FindTrial
Sign In

Eye Diseases associated with COVID-19

Screening for Retinopathy in Patients with COVID-19 - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2020/11/029393
Enrollment
30
Registered
2020-11-26
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: B972- Coronavirus as the cause of diseases classified elsewhere Health Condition 2: B972- Coronavirus as the cause of diseases classified elsewhere Health Condition 3: H308- Other chorioretinal inflammations Health Condition 4: H309- Unspecified chorioretinal inflammation

Interventions

Intervention1: NIL: NIL

Sponsors

Lilavati Hospital
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. All patients admitted with a RT-PCR proven COVID-19 infection 2. Discharged recovered patients

Exclusion criteria

Exclusion criteria: NIL

Design outcomes

Primary

MeasureTime frame
1. Detection of retinal/choroidal lesions using fundus photography/Optical coherence tomography Timepoint: 1. At any time during admission or immediate post-discharge—

Secondary

MeasureTime frame
1. any incidental ocular diseaseTimepoint: 1. at any time—

Countries

India

Contacts

Public ContactDr Salil Mehta

Lilavati Hospital and Research Center

drsalilmehta@gmail.com022-26568229

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026